Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Avanos Medical Inc (AVNS) USD0.01

Sell:$46.07 Buy:$46.08 Change: $0.66 (1.41%)
Market closed |  Prices as at close on 25 February 2021 | Switch to live prices |
Sell:$46.07
Buy:$46.08
Change: $0.66 (1.41%)
Market closed |  Prices as at close on 25 February 2021 | Switch to live prices |
Sell:$46.07
Buy:$46.08
Change: $0.66 (1.41%)
Market closed |  Prices as at close on 25 February 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Avanos Medical, Inc., formerly Halyard Health, Inc., is a medical technology company. The Company provides a portfolio of product offerings focused on surgical and interventional pain management, respiratory and digestive health. Its products include post-operative pain management solutions, minimally invasive interventional or chronic pain therapies, closed airway suction systems and enteral feeding tubes. The company’s products are sold under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, QUIKBLOC, HOMEPUMP, CORTRAK and other brand names.

Contact details

Address:
5405 Windward Parkway
ALPHARETTA
30004
United States
Telephone:
+1 (678) 4259273
Website:
https://avanos.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AVNS
ISIN:
US05350V1061
Market cap:
$2.13 billion
Shares in issue:
47.97 million
Sector:
Health Care Supplies
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Gary Blackford
    Chairman of the Board
  • Joseph Woody
    Chief Executive Officer, Director
  • Michael Greiner
    Chief Financial Officer, Senior Vice President
  • Michelle Scharfenberg
    Senior Vice President, Chief Ethics and Compliance Officer
  • S. Ross Mansbach
    Senior Vice President, Interim General Counsel, Corporate Secretary
  • William Haydon
    Senior Vice President, General Manager
  • David Ball
    Senior Vice President - Global Supply Chain and Procurement
  • Arjun Sarker
    Senior Vice President - International

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.